Brief: Adial Pharmaceuticals Inc - Nasdaq Granted Co Extension Up Until Aug 21 To File A Form 10-Q
10/07/2023 23:20
July 10 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS INC - NASDAQ GRANTED CO EXTENSION UP
UNTIL
AUG 21 TO FILE A FORM 10-Q REPORT FOR PERIOD ENDED JUNE 30, 2023
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)